Systemic lupus erythematosus - A contemporary view of its genetic determination, immunopathogenesis and therapy;Systémový lupus erythematosus - Súčasný pohlad na genetickú determináciu, imunopatogenézu a liečbu

Epidemiologie, Mikrobiologie, Imunologie

Volumn 58, Issue 1, 2009, Pages 3-14

  Buc, Milan ^a   Rovensky J ^b  

^a Imunologický Ústav Lekárskej Fakulty UK   (Slovakia)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Autoantibodies; Complement; HLA complex; Interferon signature; Monoclonal antibodies; SLE; T cells

Indexed keywords

AUTOANTIBODY; BELIMUMAB; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DANAZOL; DOUBLE STRANDED DNA; EPRATUZUMAB; ESTROGEN; FAS ANTIGEN; FAS LIGAND; FC RECEPTOR; GLUCOCORTICOID; HLA ANTIGEN; HYDROXYCHLOROQUINE; INTERFERON; INTERLEUKIN 10; MANNOSE BINDING LECTIN; METHOTREXATE; MONOCLONAL ANTIBODY; PROGESTERONE; PROTEIN BCL 2; RITUXIMAB; RO ANTIBODY; SM ANTIBODY; TUMOR NECROSIS FACTOR;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT SYSTEM; COMPLEX FORMATION; DENDRITIC CELL; GENE CONTROL; GENE IDENTIFICATION; HLA SYSTEM; HORMONE ACTION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 59849113509     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abraham, L. J., Kroeger, K. M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol, 1999, 66, 562-566.
2. Anolik, J. H., Campbell, D., Felgar, R. E., Young F. et al. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheumatism, 2003, 48, 455-459.
3. Baechler, E. C., Gregersen, P. K., Behrens, T. W. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol, 2004, 416, 801-807.
4. Banchereau, J., Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity, 2006, 25, 383-392.
5. Bijlsma, J. W., Straub, R. H., Masi, A. T., Lahita RG, Cutolo, M. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol, 2002, 23, 59-61.
6. Blanco, P., Palucka, A. K., Gill, M., Pascual, V., Banchereau. J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science, 2001, 294, 1540-1543.
7. Buc, M. Autoimunita a autoimunitné choroby. Bratislava: Veda, 2005, 491 s.
8. Buc, M. Imunológia. Bratislava: Veda, 2001, 434 s.
9. Carlsten, H., Holmdahl, R., Tarkowski, A. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunol, 1991, 73, 186-190.
10. Carroll, M. C. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol, 2004, 4, 825-831.
11. Crawford, K., Alper, C. A. Genetics of the complement system. Rev Immunogenet, 2000, 2, 323-338.
12. Crispin, J. C., Vargas, M. I., Alcocer-Varela, J. Immunoregulatory T cells in autoimmunity. Autoimmun Rev, 2004, 3, 45-51.
13. Dhaher, Y. Y., Greenstein, B. D., Khamashta, M. A., Hughes, G. R. Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb/C and MRL/Mp-Lpr/Lpr mice, a model of systemic lupus erythematosus (SLE). Autoimmunity, 2001, 33, 237-243.
14. Dorner, T., Chaoui, R., Feist, E., Goldner, B. et al. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block. J Autoimmun, 1995, 8, 675-684.
15. Dorner, T., Lipsky, P. E. Immunoglobulin variable-region gene usage in systemic autoimmune diseases. Arthritis and rheumatism, 2001, 44, 2715-2727.
16. Dostál, C. Systémový lupus erytematodes. In: Rovenský, J. Klinická reumatológia. Martin: Osveta, 2000, 275-301.
17. Dostál, C. Systémový lupus erytematosus a gravidita. In: Rovenský, J. Reumatologia v teórii a praxi. Martin: Osveta, 1998, 309-316.
18. Doyle, H. A., Yah, J., Liang, B., Mamula, M. J. Lupus autoantigens: their origins, forms, and presentation. Immunol Res, 2001, 24, 131-147.
19. Gillmore, J. D., Hutchinson, W. L., Herbert, J., Bybee, A. et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunol, 2004, 112, 255-264.
20. Harley, J. B., Moser, K. L., Gaffney, P. M., Behrens, T. W. The genetics of human systemic lupus erythematosus. Curr Opin Immunol, 1998, 10, 690-696.
21. Jara, L. J., Benitez, G., Medina, G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev, 2008, 7, 251-255.
22. Jara, L. J., Vera-Lastra, O., Miranda, J. M., Aleala M., Alvarez-Nemegyei, J. Prolactin in human systemic lupus erythematosus. Lupus 2001, 10, 748-756.
23. Katsiari, C. G., Tsokos, G. C. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. Autoimmun Reviews, 2006, 5, 118-121.
24. Kotzin, B. L., West, S. G. Systemic lupus erythematosus. In Rich R. R. Clinical Immunology Principles and practice. Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto: Mosby, 2001, 60.61-60.24.
25. Larsson, M., Fonteneau, J. F., Bhardwaj, N. Dendritic cells resurrect antigens from dead cells. Trends Immunol, 2001, 22, 141-148.
26. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 2002, 416, 603-607.
27. Lipsky, P. E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol, 2001, 2, 764-766.
28. Maloy, K. J., Powrie, F. Regulatory T cells in the control of immune pathology Nat Immunol 2001, 2, 816-822.
29. McMurray, R., Keisler, D., Kanucke, K., Izui, S., Walker, S. E. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol, 1991, 147, 3780-3787.
30. Nath, S. K., Kilpatrick, J., Harley, J. B. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol, 2004, 16, 794-800.
31. Nose, M., Nishihara, M., Kamogawa, J., Terada, M., Nakatsuru, S. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci. Rev Immunogenet, 2000, 2, 154-164.
32. Odendahl, M., Jacobi, A., Hansen, A., Feist, E. et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol, 2000, 165, 5970-5979.
33. Raman, K., Mohan, C. Genetic underpinnings of autoimmunity lessons from studies in arthritis, diabetes, lupus and multiple sclerosis. Curr Opin Immunol, 2003, 15, 651-659.
34. Ramanujam, M., Davidson, A. BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? Immunol Rev, 2008, 223, 156-174.
35. Rovenský, J. Klinická reumatológia. Martin: Osveta, 2000, 1048 s.
36. Scofield, R. H. Genetic knock out of 60kD Ro (or SSA), a common lupus autoantigen, induces lupus. Trends Immunol, 2004, 25, 1-3.
37. Shaw, T., Quan, J., Totoritis, M. C. B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience. Ann Rheum Dis, 2003, 62, Suppl. 2, 55-59.
38. Tenbrock, K., Juang, Y. T., Kyttaris, V. C., Tsokos, G. C. Altered signal transduction in SLE T cells. Rheumatol, 2007, 46, 1525-1530.
39. Teplitsky, V., Shoenfeld, Y., Tanay, A. The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans. Lupus, 2006, 15, 319-325.
40. Thome, M., Tschopp, J. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol, 2001, 1, 50-58.
41. Tsao, B. P. The genetics of human systemic lupus erythematosus. Trends Immunol, 2003, 24, 595-602.
42. Tsokos, G. C., Nambiar, M. P., Tenbrock, K., Jung, Yo T. Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE. Trends Immunol, 2003, 24, 259-263.
43. Vidaver, R. Molecular and clinical evidence of the role of estrogen in lupus. Trends Immunol, 2002, 23, 229-230.
44. Whitacre, C. C. Sex differences in autoimmune disease. Nat Immunol, 2001, 2, 777-780.
45. Woof, J. M., Burton, D. R. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol, 2004, 4, 89-99.